ALUMIS INC. (ALMS)

Latest Insider Confidence Score

2026Q1

86.6
Bullish

Company insider confidence (by quarter)

2024Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
AyurMaya Capital Management Company, LP — 15,139,707 May 23, 2025
Goel David E. — 15,139,707 May 23, 2025
Foresite Capital Management VI LLC 10% Owner 13,163,825 Nov 25, 2025
Foresite Capital Management V, LLC 10% Owner 13,163,825 Nov 25, 2025
Foresite Capital Fund V, L.P. 10% Owner 13,163,825 Nov 25, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 25, 2025 Feb 11, 2026 Goldstein David M Chief Scientific Officer Neutral 27.5 -1,000 -2.42% ✗ -
Jan 26, 2026 Jan 28, 2026 Pangali Sanam Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Jan 26, 2026 Jan 28, 2026 Babler Martin CEO Neutral 52.5 - 0.00% ✗ -
Jan 26, 2026 Jan 28, 2026 Hardiman Roy C. Chief Business & Strategy Ofcr Neutral 52.5 - 0.00% ✗ -
Jan 26, 2026 Jan 28, 2026 Bradley Mark Christopher Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Jan 26, 2026 Jan 28, 2026 Drappa Jorn Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 26, 2026 Jan 28, 2026 Schroer John R. CFO Neutral 52.5 - 0.00% ✗ -
Jan 26, 2026 Jan 28, 2026 Goldstein David M Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2026 Jan 13, 2026 AKKARAJU SRINIVAS Director Buy 100.0 +588,235 10.22% ✗ $10M
Jan 8, 2026 Jan 12, 2026 Foresite Labs, LLC 10% Owner Buy 96.3 +411,764 5.02% ✗ $7M
Jan 8, 2026 Jan 12, 2026 Foresite Capital Management VI LLC 10% Owner Buy 96.3 +411,764 5.02% ✗ $7M
Jan 8, 2026 Jan 12, 2026 Tananbaum James B. Director Buy 96.3 +411,764 5.02% ✗ $7M
Dec 5, 2025 Dec 9, 2025 AKKARAJU SRINIVAS Director Buy 92.5 +186,377 3.35% ✗ $1.8M
Dec 2, 2025 Dec 4, 2025 AKKARAJU SRINIVAS Director Buy 92.5 +262,027 4.94% ✗ $2M
Nov 26, 2025 Dec 1, 2025 AKKARAJU SRINIVAS Director Buy 92.5 +173,589 3.38% ✗ $1.3M
Nov 21, 2025 Nov 25, 2025 Foresite Capital Management VI LLC 10% Owner Buy 90.0 +72,212 2.84% ✗ $532.9K
Nov 21, 2025 Nov 25, 2025 Tananbaum James B. Director Buy 90.0 +72,212 2.84% ✗ $532.9K
Nov 21, 2025 Nov 25, 2025 Foresite Labs, LLC 10% Owner Buy 90.0 +72,212 2.84% ✗ $532.9K
Nov 20, 2025 Nov 24, 2025 AKKARAJU SRINIVAS Director Buy 90.0 +125,743 2.51% ✗ $905.3K
Nov 17, 2025 Nov 19, 2025 Foresite Labs, LLC 10% Owner Buy 100.0 +507,874 24.97% ✗ $3.1M
Nov 17, 2025 Nov 19, 2025 Foresite Capital Management VI LLC 10% Owner Buy 100.0 +507,874 24.97% ✗ $3.1M
Nov 17, 2025 Nov 19, 2025 Tananbaum James B. Director Buy 100.0 +507,874 24.97% ✗ $3.1M
Nov 17, 2025 Nov 19, 2025 AKKARAJU SRINIVAS Director Buy 95.0 +241,338 5.06% ✗ $1.5M
Nov 13, 2025 Nov 17, 2025 AKKARAJU SRINIVAS Director Buy 95.0 +276,179 6.15% ✗ $1.4M
Jul 30, 2025 Aug 1, 2025 TETRAULT LYNN A. Director Neutral 52.5 - 0.00% ✗ -
Jul 30, 2025 Aug 1, 2025 Yao Zhengbin Director Neutral 52.5 - 0.00% ✗ -
Jul 30, 2025 Aug 1, 2025 Srivastava Sapna Director Neutral 52.5 - 0.00% ✗ -
Jul 30, 2025 Aug 1, 2025 Machado Patrick Director Neutral 52.5 - 0.00% ✗ -
Jul 30, 2025 Aug 1, 2025 AKKARAJU SRINIVAS Director Neutral 52.5 - 0.00% ✗ -
Jul 29, 2025 Jul 31, 2025 Pangali Sanam Chief Legal Officer Neutral 90.0 +10,000 900.09% ✗ -
Jul 29, 2025 Jul 31, 2025 Richardson Derrick SVP, People and Culture Neutral 90.0 +42,800 100.00% ✗ -
Jul 29, 2025 Jul 31, 2025 Schroer John R. CFO Neutral 90.0 +28,000 100.00% ✗ -
Jul 29, 2025 Jul 31, 2025 Hardiman Roy C. Chief Business & Strategy Ofcr Neutral 90.0 +28,000 15.15% ✗ -
Jul 29, 2025 Jul 31, 2025 Goldstein David M Chief Scientific Officer Neutral 90.0 +27,000 12.27% ✗ -
Jul 29, 2025 Jul 31, 2025 Drappa Jorn Chief Medical Officer Neutral 90.0 +25,450 848.33% ✗ -
Jul 29, 2025 Jul 31, 2025 Bradley Mark Christopher Chief Development Officer Neutral 90.0 +26,750 43.12% ✗ -
Jul 29, 2025 Jul 31, 2025 Babler Martin CEO Neutral 52.5 - 0.00% ✗ -
Jul 10, 2025 Jul 14, 2025 Pangali Sanam Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Jul 14, 2025 Pangali Sanam Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 AKKARAJU SRINIVAS Director Neutral 90.0 +1,214,582 33.86% ✗ -
May 21, 2025 May 23, 2025 AyurMaya Capital Management Company, LP Director Neutral 90.0 +4,493,741 42.21% ✗ -
May 21, 2025 May 23, 2025 Machado Patrick Director Neutral 90.0 +7,064 100.00% ✗ -
May 23, 2025 TETRAULT LYNN A. Director Neutral 52.5 - 0.00% ✗ -
May 2, 2025 May 6, 2025 Tananbaum James B. Director Buy 82.5 +45,000 1.07% ✗ $202.3K
May 2, 2025 May 6, 2025 Foresite Labs, LLC 10% Owner Buy 82.5 +45,000 1.07% ✗ $202.3K
May 2, 2025 May 6, 2025 Foresite Capital Management VI LLC 10% Owner Buy 82.5 +45,000 1.07% ✗ $202.3K
May 2, 2025 May 6, 2025 AKKARAJU SRINIVAS Director Buy 95.0 +320,290 9.81% ✗ $1.5M
Apr 1, 2025 Apr 3, 2025 Colowick Alan Director Buy 95.0 +18,404 100.00% ✗ $129.5K
Apr 1, 2025 Apr 3, 2025 Babler Martin CEO Buy 95.0 +15,650 17.23% ✗ $100.7K
Feb 18, 2025 Feb 20, 2025 Hardiman Roy C. Chief Business & Strategy Ofcr Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 Richardson Derrick SVP, People and Culture Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 Schroer John R. CFO Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 Bradley Mark Christopher Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 Klein Sara Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 Drappa Jorn Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 Goldstein David M Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 Babler Martin CEO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Aug 27, 2024 AKKARAJU SRINIVAS Director Buy 100.0 +1,562,500 91.70% ✗ $25M
Jul 1, 2024 Jul 3, 2024 Foresite Labs, LLC 10% Owner Buy 100.0 +2,500,000 34.31% ✗ $40M
Jul 1, 2024 Jul 3, 2024 Foresite Capital Management V, LLC 10% Owner Buy 100.0 +2,500,000 34.31% ✗ $40M
Jul 1, 2024 Jul 3, 2024 Tananbaum James B. Director Buy 100.0 +2,500,000 34.31% ✗ $40M
Jul 1, 2024 Jul 3, 2024 AyurMaya Capital Management Company, LP Director Neutral 90.0 +2,500,000 30.69% ✗ -
Jul 1, 2024 Jul 1, 2024 Yao Zhengbin Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Jul 1, 2024 Srivastava Sapna Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Jul 1, 2024 Machado Patrick Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 1, 2024 AKKARAJU SRINIVAS Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Jul 1, 2024 Richardson Derrick SVP, People and Culture Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 1, 2024 Klein Sara General Counsel - Corp Secy Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Jul 1, 2024 Schroer John R. CFO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 1, 2024 Hardiman Roy C. Chief Business & Legal Officer Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 1, 2024 Goldstein David M Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Jul 1, 2024 Drappa Jorn Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 1, 2024 Bradley Mark Christopher Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 1, 2024 Babler Martin CEO Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Tananbaum James B. Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Foresite Labs, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Foresite Capital Management V, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 AyurMaya Capital Management Company, LP Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Colowick Alan Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Yao Zhengbin Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Srivastava Sapna Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Machado Patrick Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 AKKARAJU SRINIVAS Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Richardson Derrick SVP, People and Culture Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Klein Sara General Counsel - Corp Secy Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Schroer John R. CFO Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Hardiman Roy C. Chief Business & Legal Officer Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Goldstein David M Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Drappa Jorn Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Bradley Mark Christopher Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Babler Martin CEO Neutral 52.5 - 0.00% ✗ -